Previous Page Learning objectives
This section has been developed as a resource providing information on poly (ADP-ribose) polymerase (PARP) inhibitors in prostate cancer.
Information included in this section is compiled from review of the medical literature and expert guidance from Elena Castro (Spanish National Cancer Research Center, Madrid, Spain), Alexander Wyatt (University of British Columbia, British Columbia, Canada), Gerhardt Attard (University College London, United Kingdom) and Steven Joniau (University Hospitals Leuven, Belgium).
Further information on PARP activity and inhibition can be found by clicking on each topic below.